Clinical & translational oncology

• 

  Año 2017, Vol. 19, Número 3 (March 2017)

  • Editorial

    • The oncology day hospital in Spain: an updated analysis of Spanish Society of Medical Oncology (SEOM) looking forward

      Carlos Jara Sánchez, Francisco Ayala de la Peña, Juan Antonio Virizuela Echaburu

      págs. 269-272

      

  • Review Article

    • Combining PARP inhibitors with radiation therapy for the treatment of glioblastoma: Is PTEN predictive of response?

      A. Lester, R. Rapkins, S. Nixdorf, M. Khasraw, K. McDonald

      • Resumen

      págs. 273-278

      

    • Consensus on the management of advanced radioactive iodine-refractory differentiated thyroid cancer on behalf of the Spanish Society of Endocrinology Thyroid Cancer Working Group (GTSEEN) and Spanish Rare Cancer Working Group (GETHI)

      Jaume Capdevila Castillon, Juan Carlos Galofré Ferrater, Enrique Grande Pulido, Carles Zafón Llopis, Teresa Ramón y Cajal, Elena Navarro González, P. Jiménez Fonseca, Francisco Javier Santamaría Sandi, José Manuel Gómez Sáez, Garcilaso Riesco Eizaguirre

      • Resumen

      págs. 279-287

      

  • Special Article

    • European edition of the NCCN clinical practice guidelines: relevance of the translation and adaptation into Spanish

      Vicente Guillem Porta, Carlos Camps Herrero, Alfredo Carrato Mena, Eduardo Díaz-Rubio García, Pedro Gascón Vilaplana

      • Resumen

      págs. 288-290

      

    • New clinical trials regulation in Spain: analysis of royal decree 1090/2015

      Miguel Martín Jiménez, Aitana Calvo Ferrándiz, Jorge Aparicio Urtasun, María Rosario García Campelo, E. González Flores, Martin Lázaro Quintela, Montserrat Muñoz, César Augusto Rodríguez Sánchez, Ana Santaballa Bertrán, Juan Manuel Sepúlveda Sánchez, Ruth Vera García, Juan Antonio Virizuela Echaburu, Miguel Ángel Seguí Palmer

      • Resumen

      págs. 291-300

      

  • Research Article

    • Incidence and survival time trends for Spanish children and adolescents with leukaemia from 1983 to 2007

      Rafael Marcos Gragera, Jaume Galceran Padrós, María del Carmen Martos Jiménez, Arantza López de Munain Marques, Marisa Vicente Raneda, Carmen Navarro Sánchez, José Ramón Quirós García, María José Sánchez Pérez, Eva Ardanaz Aicua, María José Ramos Monserrat, Antonio Mateos Ramos, Diego Salmerón Martínez, S. Felipe, Rafael Peris Bonet

      • Resumen

      págs. 301-316

      

    • Salvage treatment with irinotecan/cisplatin versus pemetrexed/cisplatin in patients with non-small cell lung cancer pre-treated with a non-platinum-based regimen in the first-line setting: a randomized phase II study of the Hellenic Oncology Research Group (HORG)

      N. Kentepozidis, P. Economopoulou, Ch. Christofyllakis, L. Chelis, A. Polyzos, N. Vardakis, F. Koinis, L. Vamvakas, P. Katsaounis, K. Kalbakis, Ch. Nikolaou, V. Georgoulias, A. Kotsakis

      • Resumen

      págs. 317-325

      

    • M30/M65 ratio predicts the outcome of paclitaxel chemotherapy for NSCLC

      T. Chu, L. Jiang, W. Ying, B. Han

      • Resumen

      págs. 326-331

      

    • Urinary circulating DNA detection for dynamic tracking of EGFR mutations for NSCLC patients treated with EGFR-TKIs

      S. Chen, J. Zhao, L. Cui, Y. Liu

      • Resumen

      págs. 332-340

      

    • Equity, barriers and cancer disparities: study of the Spanish Society of Medical Oncology on the access to oncologic drugs in the Spanish Regions

      Javier Salvador Bofill, Jorge Aparicio Urtasun, Francisco Javier Barón Duarte, María Rosario García Campelo, Rocío García Carbonero, Pilar Lianes Barragán, Antonio Llombart Cussac, Dolores Isla Casado, Josep Manuel Piera Pibernat, Montserrat Muñoz, Javier Puente Vázquez, Fernando Rivera Herrero, César Augusto Rodríguez Sánchez, Juan Antonio Virizuela Echaburu, Miguel Martín Jiménez, María Pilar Garrido López

      • Resumen

      págs. 341-356

      

    • Clinical behavior of solitary fibrous tumor: a retrospective review of 30 patients

      María Ángeles Vaz Salgado, M. Soto, María Eugenia Reguero Callejas, Gemma María Muñoz Molina, A. Cabañero, José Ignacio Gallego Rivera, S. Resano Pardo, Federico Longo Muñoz, Ainhoa Madariaga Urrutia, Ana Gomez Rueda, Alfredo Carrato Mena

      • Resumen

      págs. 357-363

      

    • Identification of clinical biomarkers for patients with advanced hepatocellular carcinoma receiving sorafenib

      Ángela Lamarca Lete, Omar Mohammed Abdel-Rahman, I. Salu, M. G. McNamara, Juan W. Valle, R. A. Hubner

      • Resumen

      págs. 364-372

      

    • Intermittent versus continuous androgen deprivation therapy to biochemical recurrence after external beam radiotherapy: a phase 3 GICOR study

      Francesc Casas, I. Henríquez, Amelia Béjar Luque, Javier Maldonado Pijoan, A. Álvarez González, Carmen González San Segundo, Ana Boladeras Inglada, Ferran Ferrer González, Asunción Hervás Morón, Ismael Herruzo Cabrera, Mónica Caro Gallarín, Isabel Rodríguez Rodríguez, Carlos Ferrer Albiach

      • Resumen

      págs. 373-378

      

    • Mid-term oncologic outcome of a novel approach for locally advanced colon cancer with neoadjuvant chemotherapy and surgery

      Jorge Arredondo Chaves, Jorge Baixauli Fons, Carlos Pastor Idoate, Ana Chopitea Ortega, Jesús J. Sola, I. González, Javier Álvarez Cienfuegos Suárez, P. Martínez Ortega, Javier Rodríguez, José Luis Hernández Lizoain

      • Resumen

      págs. 379-385

      

    • Performance of the clinical index of stable febrile neutropenia (CISNE) in different types of infections and tumors

      Alberto Carmona Bayonas, P. Jiménez Fonseca, Juan Antonio Virizuela Echaburu, Maite Antonio, Carme Font Puig, Mercedes Biosca Gomez de Tejada, Avi Ramchandani Vaswani, Jerónimo Martinez Garcia, Jorge Hernando Cubero, Javier Espinosa Arranz, Eva Martínez de Castro, Ismael Ghanem Cañete, Carmen Beato Zambrano, Ana Blasco Cordellat, M. Garrido, Rebeca Mondéjar Solís, Àngels Arcusa Lanza, Isabel Aragón Manrique, A. Manzano, Elena Sevillano Fernández, Eduardo Castañón, Francisco Ayala de la Peña

      • Resumen

      págs. 386-395

      

  • Acknowledgement to Reviewers

    • Thanks to reviewers

      págs. 396-398